Global Health Share Price | Global Health Stock Screener
MEDANTA
Hospitals
Share Price NSE
₹1378.20
▲
24.80 (1.83%)
Share Price BSE
₹1374.05
▲
20.30 (1.50%)
As of July 23, 2026, the Global Health share price (NSE: MEDANTA) is ₹1,378.20 on NSE and ₹1,374.05 on BSE, up 1.83% from the previous close, with shares trading between ₹1,350.70 and ₹1,402.00, and a 52-week range of ₹961.10–₹1,428.30.
Analyse MEDANTA share price history and track historical price performance.
Use the Global Health stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Global Health Market Cap
₹36,098.19 Cr.
MEDANTA P/E Ratio (TTM)
64.62
Global Health P/B Ratio
9.04
EPS (TTM)
₹20.71
Dividend Yield
-
Debt to Equity
0.24
MEDANTA 52 Week High
₹1428.30
Global Health 52 Week Low
₹961.10
Operating Margin
21.00%
Profit Margin
11.87%
MEDANTA Revenue (TTM)
₹1,196.00
EBITDA
₹281.00
Net Income
₹142.00
Total Assets
₹5,905.00
Total Equity
₹3,962.00
Global Health Share Price Chart
Screen Global Health share price with an interactive chart. Analyse MEDANTA price trends and volatility across different timeframes.
Global Health Company Profile - Fundamental Screener
Screen Global Health company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for MEDANTA shares.
Global Health Limited is a private multi-specialty tertiary care provider operating in North and East India. Founded by Dr. Naresh Trehan, the company operates under the Medanta brand with a network of 5 operational hospitals and one under construction. As of June 30, 2022, they offered healthcare services in over...more
Sector
Healthcare Services
Industry
Hospitals
Sub-Sector
Hospitals
Segment
E
Chairperson/CEO
Naresh Kumar Trehan
ISIN
INE474Q01031
Website
https://www.medanta.org
Global Health Balance Sheet Screener
Screen MEDANTA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total Assets | 5,905 | 4,766 | 4,304 | 4,116 | 3,146 | 2,694 | 0 | 2,430 | 1,984 |
| Current Assets | 1,675 | 1,533 | 1,509 | 1,580 | 812 | 502 | 0 | 489 | 472 |
| Fixed Assets | 3,927 | 2,514 | 2,236 | 2,050 | 1,776 | 1,616 | 0 | 1,194 | 1,094 |
| Liabilities | |||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 1,294 | 760 | 781 | 1,115 | 1,110 | 907 | 0 | 839 | 432 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||||
| Total Equity | 3,962 | 3,388 | 2,906 | 2,428 | 1,616 | 1,382 | 0 | 1,296 | 1,217 |
| Share Capital | 54 | 54 | 54 | 54 | 51 | 50 | 0 | 49 | 81 |
| Reserves & Surplus | 3,908 | 3,333 | 2,852 | 2,375 | 1,565 | 1,300 | 0 | 1,214 | 1,136 |
Global Health Income Statement Screener - Profit & Revenue Analysis
Screen Global Health income statement and profit fundamentals.
Analyze MEDANTA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Global Health share price evaluation.
| Item | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,196 | 1,143 | 1,135 | 1,051 | 954 | 960 | 975 | 883 | 836 | 855 | 865 | 795 | 732 | 706 | 695 |
| Expenses | 915 | 940 | 868 | 784 | 757 | 706 | 728 | 675 | 629 | 621 | 631 | 595 | 540 | 534 | 523 |
| EBITDA | 281 | 203 | 267 | 267 | 198 | 254 | 247 | 208 | 207 | 234 | 234 | 199 | 192 | 172 | 172 |
| Operating Profit % | 21.00% | 16.00% | 21.00% | 24.00% | 19.00% | 25.00% | 24.00% | 22.00% | 22.00% | 26.00% | 25.00% | 24.00% | 24.00% | 23.00% | 23.00% |
| Depreciation | 67 | 61 | 50 | 45 | 49 | 49 | 49 | 47 | 46 | 44 | 43 | 40 | 38 | 39 | 37 |
| Interest | 27 | 22 | 17 | 14 | 15 | 16 | 16 | 18 | 18 | 18 | 20 | 18 | 21 | 21 | 18 |
| Profit Before Tax | 187 | 120 | 200 | 208 | 133 | 189 | 181 | 144 | 143 | 172 | 171 | 141 | 133 | 112 | 117 |
| Tax | 46 | 25 | 41 | 49 | 32 | 46 | 50 | 37 | 16 | 49 | 45 | 39 | 32 | 32 | 31 |
| Net Profit | 142 | 95 | 158 | 159 | 101 | 143 | 131 | 106 | 127 | 124 | 125 | 102 | 101 | 81 | 86 |
| EPS | 5.36 | 3.54 | 5.89 | 5.92 | 3.77 | 5.32 | 4.87 | 3.96 | 4.74 | 4.61 | 4.66 | 3.80 | 3.77 | 3.08 | 3.38 |
Global Health Cash Flow Screener - Liquidity Fundamentals
Screen MEDANTA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 624 | 612 | 645 | 311 | 242 | 175 | 166 | 63 | 228 | 213 |
| Investing Activities | -721 | -441 | -342 | -421 | -239 | -87 | -249 | -69 | -241 | -126 |
| Financing Activities | -97 | -514 | 346 | 160 | -81 | -1 | 97 | 9 | -7 | -88 |
| Net Cash Flow | -194 | -343 | 648 | 50 | -78 | 87 | 14 | 3 | -20 | 0 |
Global Health Shareholding Pattern Screener
See Global Health shareholding pattern with promoter, FII, and DII holdings.
Check Global Health promoter holding and ownership changes for MEDANTA on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 33.01% | 33.03% | 33.01% | 33.01% | 33.01% | 33.04% | 33.04% | 33.04% |
| FII Holding | 10.15% | 11.76% | 11.54% | 11.40% | 10.53% | 12.09% | 12.94% | 12.20% |
| DII Holding | 14.77% | 11.93% | 12.20% | 12.98% | 14.00% | 10.25% | 10.57% | 11.11% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 5.88% | 6.53% | 6.48% | 6.03% | 5.95% | 7.14% | 6.28% | 6.54% |
| Other Holding | 36.20% | 36.75% | 36.77% | 36.58% | 36.51% | 37.47% | 37.16% | 37.10% |
| Shareholder Count | 147,390 | 154,688 | 156,372 | 155,806 | 151,241 | 166,253 | 155,307 | 149,722 |
Global Health Share Dividend Screener - Share Yield Analysis
Check Global Health dividend history with payout and yield data.
View Global Health dividend details including ex-dates and amounts for MEDANTA stock.
Global Health Stock Index Membership
See which indices include Global Health stock.
Check MEDANTA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX BSEIPO
BSE INDEX LMI250
BSE INDEX MID150
BSE INDEX MSL400
BSE INDEX SMLCAP
BSE INDEX SMLSEL
NIFTY 500
NIFTY LARGEMID250
NIFTY MIDCAP 150
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
NIFTY500 SHARIAH
Global Health Market Events Screener - Corporate Actions
Get Global Health corporate actions including splits, bonuses, and buybacks.
Check Global Health stock events that may affect MEDANTA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-14 | 2026-05-14 | Quarterly Result Announcement | NA | 2.20% |
| 2026-02-04 | 2026-02-04 | Quarterly Result Announcement | NA | 8.16% |
| 2025-11-07 | 2025-11-07 | Quarterly Result Announcement | NA | -5.04% |
| 2025-09-19 | 2025-09-19 | Annual General Meeting | NA | 2.14% |
| 2025-08-22 | 2025-08-22 | Dividend | ₹ 0.50 /share | 11.88% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -1.20% |
| 2025-05-15 | 2025-05-15 | Quarterly Result Announcement | NA | 3.17% |
| 2025-02-04 | 2025-02-04 | Quarterly Result Announcement | NA | 4.13% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -3.80% |
| 2024-09-19 | 2024-09-19 | Annual General Meeting | NA | -6.51% |
| 2024-08-03 | 2024-08-03 | Extraordinary General Meeting | NA | -7.46% |
Global Health Competitors Screener - Peer Comparison
Screen MEDANTA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 128,349 | 63.97 | 25,229 | 14.70% | 2,032 | 64.73 |
| Max Healthcare Institute | 107,096 | 74.35 | 8,536 | 18.82% | 1,442 | 53.46 |
| Fortis Healthcare | 73,155 | 67.51 | 9,179 | 16.93% | 1,064 | 52.56 |
| Aster DM Healthcare | 42,147 | 166.24 | 4,643 | 8.32% | 384 | 58.37 |
| Narayana Hrudayalaya | 40,825 | 51.37 | 7,896 | 41.63% | 788 | 54.04 |
| Global Health | 36,098 | 64.62 | 4,410 | 16.94% | 584 | 60.06 |
| Krishna Institute of Medical Sciences | 33,199 | 136.90 | 3,905 | 27.31% | 198 | 46.69 |
| Dr. Agarwal's Health Care | 15,399 | 91.34 | 2,080 | 18.39% | 168 | 55.83 |
| Rainbow Childrens Medicare | 15,068 | 53.78 | 1,747 | 11.49% | 282 | 62.78 |
| Park Medi World | 11,692 | 44.08 | 1,679 | 17.77% | 272 | 44.04 |
Global Health Company Announcements - News Screener
Screen MEDANTA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-07-23 | Board Meeting Intimation for Schedule Of Board Meeting For The First Quarter Ended June 30 2026 Under Regulation 29 Of Listing Regulations. | - |
| 2026-07-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-25 | Closure of Trading Window | - |
| 2026-06-24 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-06-23 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-06-23 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-06-18 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-06-18 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-06-18 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-06-17 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-06-17 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-06-16 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-06-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-06-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-06-12 | Announcement Under Regulation 30 (LODR) - Update On Establishment Of Medical College | - |
| 2026-06-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-06-08 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-06-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-06-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-06-01 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |